targeted therapies for dlbcl treatment
Published 4 years ago • 96 plays • Length 0:42Download video MP4
Download video MP3
Similar videos
-
2:15
vipor: a multi-targeted therapy for the treatment of r/r dlbcl
-
1:47
the potential clinical implications of targeted therapies for dlbcl and why the situation is complex
-
1:04
the potential of targeted therapy in dlbcl: open questions
-
2:21
targeting b-cell receptor signaling with btk degraders to treat cll
-
2:18
the need for more effective, less toxic therapies in frontline dlbcl treatment
-
2:10
should we treat high-risk dlbcl differently?
-
1:56
the need for new treatment strategies for patients with dlbcl
-
1:45
improving the frontline treatment of dlbcl
-
3:46
battling relapsed diffuse large b-cell lymphoma (dlbcl) - sam's story
-
10:09
understanding diffuse large b-cell lymphoma with jennifer amengual, md
-
10:07
understanding diffuse large b-cell lymphoma with bruce cheson, md, facp, faaas, fasco
-
0:46
advancements in the dlbcl treatment landscape
-
1:30
the use of targeted drug therapy for aggressive lymphoma
-
10:51
update of targeted or chemotherapy-free therapies in lymphoma
-
2:21
the role of molecular subtyping in dlbcl and implications for treatment decisions
-
2:48
btk inhibitors in the treatment of dlbcl: trials investigating these agents
-
4:20
treating bing-neel syndrome: chemotherapy and btk inhibitors
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
3:04
applying molecular understanding of dlbcl to management strategies
-
1:05
identifying high-risk dlbcl and optimizing treatment for these patients
-
2:18
next-generation covalent btkis in the cll treatment landscape
-
1:53
the current immunotherapeutic landscape for treatment of dlbcl